Bibliographic record

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the…

Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA. JAMA 2024

§1Bibliographic record

Authors: Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA
Title: Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
Source: JAMA
Year: 2024
Volume, issue, pages: 331(1):38–48
Digital object identifier: 10.1001/jama.2023.24945
PubMed identifier: 38078870
Record type: Journal article
Institute identifier: CEI-BR-002

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Tirzepatide	Compound monograph
Synthesis: Tirzepatide in obesity and overweight in adults: effect on the anchor…	Evidence synthesis
Synthesis: Tirzepatide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Tirzepatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Tirzepatide in obstructive sleep apnoea with obesity: effect on the…	Evidence synthesis
Synthesis: Tirzepatide in obesity and overweight in adults: tolerability and…	Evidence synthesis
Synthesis: Tirzepatide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Tirzepatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Tirzepatide in obstructive sleep apnoea with obesity: tolerability…	Evidence synthesis
Synthesis: Tirzepatide in obesity and overweight in adults: durability of effect	Evidence synthesis
Synthesis: Tirzepatide in type 2 diabetes mellitus: durability of effect	Evidence synthesis
11 citing documents.

tirzepatide maintenance SURMOUNT

Compound Evidence Institute · CEI-BR-002 · https://compoundevidence.com/bibliography/aronne2024/ · retrieved 30 July 2026